215 related articles for article (PubMed ID: 20847074)
1. Treatment of tuberculosis: update 2010.
Yew WW; Lange C; Leung CC
Eur Respir J; 2011 Feb; 37(2):441-62. PubMed ID: 20847074
[TBL] [Abstract][Full Text] [Related]
2. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.
Skrahin A; Ahmed RK; Ferrara G; Rane L; Poiret T; Isaikina Y; Skrahina A; Zumla A; Maeurer MJ
Lancet Respir Med; 2014 Feb; 2(2):108-22. PubMed ID: 24503266
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
[TBL] [Abstract][Full Text] [Related]
9. The treatment of multidrug-resistant tuberculosis in Turkey.
Tahaoğlu K; Törün T; Sevim T; Ataç G; Kir A; Karasulu L; Ozmen I; Kapakli N
N Engl J Med; 2001 Jul; 345(3):170-4. PubMed ID: 11463011
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
11. Adjunct immunotherapies for tuberculosis.
Uhlin M; Andersson J; Zumla A; Maeurer M
J Infect Dis; 2012 May; 205 Suppl 2():S325-34. PubMed ID: 22457298
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
Mishin VIu; Chukanov VI; Vasil'eva IA
Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
[TBL] [Abstract][Full Text] [Related]
13. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of tuberculosis - update 2011].
von Groote-Bidlingmaier F; Diacon AH
Ther Umsch; 2011 Jul; 68(7):395-401. PubMed ID: 21728158
[TBL] [Abstract][Full Text] [Related]
15. [Difficulties in the treatment of pulmonary tuberculosis in children].
Brînză N; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Panova LV; Ovsiankina ES
Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
[TBL] [Abstract][Full Text] [Related]
18. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.
Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):523-8. PubMed ID: 15457152
[TBL] [Abstract][Full Text] [Related]
19. [The role of bacteriology in the treatment of tuberculosis; the Hungarian program].
Fodor T
Orv Hetil; 2000 Sep; 141(36):1981-3. PubMed ID: 11031835
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
